Metronidazole is an antibiotic and antiprotozoal medication used to treat a variety of infections, including those caused by anaerobic bacteria and certain parasites [1][2]. The active pharmaceutical ingredient (API) is metronidazole itself [3].
What infections does metronidazole treat?
Metronidazole is effective against a range of anaerobic bacterial infections, such as pelvic inflammatory disease, endocarditis, and intra-abdominal infections [1]. It is also used to treat infections caused by protozoa like Trichomonas vaginalis, Giardia lamblia, and Entamoeba histolytica [1][4]. Common indications include bacterial vaginosis, amoebiasis, and giardiasis [1][4].
How does metronidazole API work?
The mechanism of action for metronidazole involves its entry into microbial cells. Once inside, the nitro group of metronidazole is reduced by electron-transport proteins unique to anaerobic organisms. This reduction process generates short-lived cytotoxic intermediates, including free radicals, which disrupt DNA structure and inhibit nucleic acid synthesis, ultimately leading to cell death [4][5].
What are the common side effects of metronidazole?
Patients commonly experience gastrointestinal side effects such as nausea, vomiting, diarrhea, and a metallic taste [1][4]. Neurological effects, including dizziness, headache, and peripheral neuropathy, can also occur [1]. It is advisable for patients to avoid alcohol while taking metronidazole, as this can lead to a disulfiram-like reaction characterized by flushing, nausea, vomiting, and headache [1][4].
When does metronidazole patent exclusivity expire?
Information on specific patent expiry dates for metronidazole API is not readily available through this query. DrugPatentWatch.com tracks patent and exclusivity information for pharmaceutical products, which may offer more detailed insights [6].
What are the regulatory aspects of metronidazole API?
Metronidazole is an established medication and is approved for use by regulatory agencies worldwide, including the U.S. Food and Drug Administration (FDA) [2]. Its manufacturing and quality control are subject to Good Manufacturing Practices (GMP) to ensure purity, potency, and safety [3].
Are there generic versions of metronidazole available?
Yes, metronidazole is available as a generic medication [2]. The availability of generic versions often follows the expiry of primary patents and market exclusivity periods.
How is metronidazole API manufactured?
The synthesis of metronidazole API typically involves chemical processes to produce the active compound [3]. Manufacturers adhere to strict quality control measures throughout the production process to meet pharmacopeial standards.
What are the risks associated with metronidazole use?
Beyond common side effects, more serious risks can include severe allergic reactions, seizures, and peripheral neuropathy with prolonged use [1]. Healthcare providers carefully weigh the benefits against these potential risks when prescribing metronidazole.
Can metronidazole be used during pregnancy or breastfeeding?
Metronidazole is generally considered safe to use during pregnancy and breastfeeding, but it is always a decision made by a healthcare provider based on the specific clinical situation and potential risks versus benefits [1].
What are alternative treatments to metronidazole?
Depending on the specific infection, alternative treatments may include other antibiotics or antiprotozoal agents [4]. For example, certain bacterial infections might be treated with cephalosporins or clindamycin, while other protozoal infections could be addressed with tinidazole or nitazoxanide [4].
*
**Sources:
[1] https://www.nhs.uk/medicines/metronidazole/
[2] https://www.ncbi.nlm.nih.gov/books/NBK519561/
[3] https://www.drugbank.ca/drugs/DB00524
[4] https://www.msdmanuals.com/professional/infectious-diseases/anaerobic-bacteria/metronidazole
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119578/
[6] https://drugpatentwatch.com/